TZIANABOS ARTHUR 4
4 · Stoke Therapeutics, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
TZIANABOS ARTHUR
DirectorInterim Executive Chair
Transactions
- Award
Stock Option (Right to Buy)
2025-03-20+122,651→ 122,651 totalExercise: $8.33Exp: 2035-03-19→ Common Stock (122,651 underlying)
Footnotes (1)
- [F1]The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.